Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study to Evaluate the Safety of Long-Term Administration of Product 33525 in Subjects With Tinea Pedis, Tinea Corporis, or Tinea Cruris

NCT01349998 is registered in ClinicalTrials.gov with Tinea Pharmaceuticals as lead sponsor.

NCT NCT01349998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01349998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study to Evaluate the Safety of Long-Term Administration of Product 33525 in Subjects With Tinea Pedis, Tinea Corporis, or Tinea Cruris
Lead sponsor
Tinea Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
September 30, 2012
Enrollment
604 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

tinea corporis, tinea cruris, tinea pedis